Literature DB >> 21609484

Patient discomfort associated with the use of intra-arterial iodinated contrast media: a meta-analysis of comparative randomized controlled trials.

Peter A McCullough1, Patrizio Capasso.   

Abstract

BACKGROUND: Discomfort characterized by pain and warmth are common adverse effects associated with the use of intra-arterial iodinated contrast media (CM). The objective of this review was to pool patient-reported outcomes available from head-to-head randomized controlled trials (RCTs) and to compare the discomfort rates associated with iso-osmolar contrast media (IOCM; i.e., iodixanol) to those reported with various low-osmolar contrast media (LOCM).
METHODS: A review of the literature published between 1990 and 2009 available through Medline, Medline Preprints, Embase, Biological Abstracts, BioBase, Cab Abstracts, International Pharmaceutical Abstracts, Life Sciences Collection, Inside Conferences, Energy Database, Engineering Index and Technology Collection was performed to compare rates of discomfort associated with the use of the IOCM (iodixanol) vs. various LOCM agents in head-to-head RCTs. All trials with a Jadad score ≥2 that reported patient discomfort data following intra-arterial administration of CM were reviewed, coded, and extracted.
RESULTS: A total of 22 RCTs (n = 8087) were included. Overall discomfort (regardless of severity) was significantly different between patients receiving IOCM and various LOCMs (risk difference [RD] -0.049; 95% confidence interval [CI]: -0.076, -0.021; p = 0.001). IOCM was favored over all LOCMs combined with a summary RD value of -0.188 (95% CI: -0.265, -0.112; p < 0.001) for incidence of pain, regardless of severity. A greater reduction in the magnitude of pain was observed with IOCM (iodixanol), particularly with selective limb and carotid/intracerebral procedures. Similarly, the meta-analysis of warmth sensation, regardless of severity, favored IOCM over LOCMs with an RD of -0.043 (95% CI: -0.074, -0.011; p = 0.008). A positive linear relationship was observed between the discomfort effect size and age and a negative relationship with increasing proportion of women. The opposite trends were observed with warmth sensation.
CONCLUSIONS: IOCM was associated with less frequent and severe patient discomfort during intra-arterial administration. These data support differences in osmolality as a possible determinant of CM discomfort.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21609484      PMCID: PMC3125247          DOI: 10.1186/1471-2342-11-12

Source DB:  PubMed          Journal:  BMC Med Imaging        ISSN: 1471-2342            Impact factor:   1.930


  36 in total

Review 1.  2009 focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update) a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

Authors:  Frederick G Kushner; Mary Hand; Sidney C Smith; Spencer B King; Jeffrey L Anderson; Elliott M Antman; Steven R Bailey; Eric R Bates; James C Blankenship; Donald E Casey; Lee A Green; Judith S Hochman; Alice K Jacobs; Harlan M Krumholz; Douglass A Morrison; Joseph P Ornato; David L Pearle; Eric D Peterson; Michael A Sloan; Patrick L Whitlow; David O Williams
Journal:  J Am Coll Cardiol       Date:  2009-12-01       Impact factor: 24.094

2.  Double-blind, randomized comparison of iodixanol 320 and iohexol 300 for cerebral angiography.

Authors:  V C Poirier; L H Monsein; P D Newberry; B J Kreps
Journal:  Invest Radiol       Date:  1994-06       Impact factor: 6.016

3.  A double-blind study comparing safety, tolerability and efficacy of iodixanol 320 mgI/ml and ioxaglate 320 mgI/ml in cerebral arteriography.

Authors:  Y Palmers; D De Greef; B H Grynne; J Smits; E Put
Journal:  Eur J Radiol       Date:  1993-11       Impact factor: 3.528

4.  Iodixanol in abdominal digital subtraction angiography. A randomized, double-blind, parallel trial with iodixanol and iohexol.

Authors:  K Singh; R Sundgren; B Bolstad; L Björk; M Lie
Journal:  Acta Radiol       Date:  1993-05       Impact factor: 1.990

5.  Evaluation of intravascular low-osmolality contrast agents.

Authors:  D P Swanson; J H Thrall; P C Shetty
Journal:  Clin Pharm       Date:  1986-11

6.  Iodixanol in femoral arteriography (phase III): a comparative double-blind parallel trial between iodixanol and iopromide.

Authors:  N D Pugh; G R Sissons; M S Ruttley; K J Berg; J O Nossen; H Eide
Journal:  Clin Radiol       Date:  1993-02       Impact factor: 2.350

7.  Iodixanol in cardioangiography. A double-blind parallel comparison between iodixanol 320 mg I/ml and ioxaglate 320 mg I/ml.

Authors:  K Tveit; K D Bolz; B Bolstad; T Haugland; K J Berg; T Skjaerpe; Y F Kloster
Journal:  Acta Radiol       Date:  1994-11       Impact factor: 1.990

8.  Iodixanol, a new isosmotic nonionic contrast agent compared with iohexol in cardiac angiography.

Authors:  J A Hill; M B Cohen; W H Kou; G B Mancini; M Mansour; H Fountaine; J A Brinker
Journal:  Am J Cardiol       Date:  1994-07-01       Impact factor: 2.778

9.  Iodixanol in cardioangiography in patients with coronary artery disease. Tolerability, cardiac and renal effects.

Authors:  N E Kløw; K Levorstad; K J Berg; U Brodahl; K Endresen; D T Kristoffersen; B Laake; S Simonsen; A J Tofte; B Lundby
Journal:  Acta Radiol       Date:  1993-01       Impact factor: 1.990

10.  Iodixanol and ioxaglate in cardioangiography: a double-blind randomized phase III study.

Authors:  P E Andersen; B Bolstad; K J Berg; P Justesen; P Thayssen; Y F Kloster
Journal:  Clin Radiol       Date:  1993-10       Impact factor: 2.350

View more
  7 in total

Review 1.  2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  Marie D Gerhard-Herman; Heather L Gornik; Coletta Barrett; Neal R Barshes; Matthew A Corriere; Douglas E Drachman; Lee A Fleisher; Francis Gerry R Fowkes; Naomi M Hamburg; Scott Kinlay; Robert Lookstein; Sanjay Misra; Leila Mureebe; Jeffrey W Olin; Rajan A G Patel; Judith G Regensteiner; Andres Schanzer; Mehdi H Shishehbor; Kerry J Stewart; Diane Treat-Jacobson; M Eileen Walsh
Journal:  Circulation       Date:  2016-11-13       Impact factor: 29.690

2.  Asia-Pacific Consensus Statement on the Management of Peripheral Artery Disease: A Report from the Asian Pacific Society of Atherosclerosis and Vascular Disease Asia-Pacific Peripheral Artery Disease Consensus Statement Project Committee.

Authors:  Maria Teresa B Abola; Jonathan Golledge; Tetsuro Miyata; Seung-Woon Rha; Bryan P Yan; Timothy C Dy; Marie Simonette V Ganzon; Pankaj Kumar Handa; Salim Harris; Jiang Zhisheng; Ramakrishna Pinjala; Peter Ashley Robless; Hiroyoshi Yokoi; Elaine B Alajar; April Ann Bermudez-Delos Santos; Elmer Jasper B Llanes; Gay Marjorie Obrado-Nabablit; Noemi S Pestaño; Felix Eduardo Punzalan; Bernadette Tumanan-Mendoza
Journal:  J Atheroscler Thromb       Date:  2020-07-04       Impact factor: 4.928

Review 3.  Subclinical acute kidney injury (AKI) due to iodine-based contrast media.

Authors:  Claudio Ronco; Fulvio Stacul; Peter A McCullough
Journal:  Eur Radiol       Date:  2012-08-16       Impact factor: 5.315

Review 4.  [Contrast medium-induced renal failure : Useful protective measures prior to contrast medium administration].

Authors:  J Wiora; R Westenfeld
Journal:  Internist (Berl)       Date:  2019-09       Impact factor: 0.743

Review 5.  2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  Marie D Gerhard-Herman; Heather L Gornik; Coletta Barrett; Neal R Barshes; Matthew A Corriere; Douglas E Drachman; Lee A Fleisher; Francis Gerry R Fowkes; Naomi M Hamburg; Scott Kinlay; Robert Lookstein; Sanjay Misra; Leila Mureebe; Jeffrey W Olin; Rajan A G Patel; Judith G Regensteiner; Andres Schanzer; Mehdi H Shishehbor; Kerry J Stewart; Diane Treat-Jacobson; M Eileen Walsh
Journal:  Circulation       Date:  2016-11-13       Impact factor: 29.690

6.  Contrast Dose and Radiation Dose Reduction in Abdominal Enhanced Computerized Tomography Scans with Single-phase Dual-energy Spectral Computerized Tomography Mode for Children with Solid Tumors.

Authors:  Tong Yu; Jun Gao; Zhi-Min Liu; Qi-Feng Zhang; Yong Liu; Ling Jiang; Yun Peng
Journal:  Chin Med J (Engl)       Date:  2017-04-05       Impact factor: 2.628

7.  Intra-arterial and intravenous applications of Iosimenol 340 injection, a new non-ionic, dimeric, iso-osmolar radiographic contrast medium: phase 2 experience.

Authors:  Karoline Meurer; Michael Laniado; Norbert Hosten; Bettina Kelsch; Barry Hogstrom
Journal:  Acta Radiol       Date:  2014-06-17       Impact factor: 1.990

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.